Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexCryptocurrenciesCybersecurityPress Releases

PerkinElmer divests three business units in $2.45 bln deal

08/01/2022 | 01:19pm EDT

Aug 1 (Reuters) - PerkinElmer Inc on Monday agreed to sell three of its businesses to private equity firm New Mountain Capital for up to $2.45 billion in cash, as it looks to focus on its life sciences and diagnostics businesses under a new name.

The latest deal is among a wave of recent corporate carve-outs and spinoffs. Last week, 3M Co announced it would spin off its healthcare unit, while Labcorp agreed to separate its clinical development business.

Direct lenders led by Owl Rock Capital Corp helped finance the deal entirely, amid a slowdown in the business of acquisition financing as both traditional and direct lenders have pulled back from lending on leveraged buyouts in recent weeks.

Proceeds from the divestiture will be used to invest in growth in the life sciences and diagnostics segments and to fund future acquisitions, PerkinElmer said. Diagnostics will generate around 60% of the company’s 2022 estimated revenue of $3.3 billion, while life sciences will account for the remainder.

The sale marked the conclusion of a strategic review where other options, including a spinoff of the units, were also considered, according to a source familiar with the matter.

The sale process included both strategic and private equity suitors, the source said, requesting anonymity as these discussions were confidential.

The price tag of the three units - applied, food, and enterprise services - implies a valuation of about 14 to 16 times the company's 2022 estimated EBITDA (earnings before interest taxes depreciation and amortization), the source said.

Shares of PerkinElmer closed up 5% at $160.87 on Monday. The transaction is expected to close in the first quarter of 2023, subject to regulatory approvals.

PerkinElmer will receive $2.3 billion when the deal closes, while the remaining $150 million will be paid to the company later, contingent on the businesses reaching certain return milestones under New Mountain's ownership.

The divested businesses will continue to use the PerkinElmer brand, while the life sciences and diagnostics businesses that remain will be run by the existing management under a new name and stock ticker that will be announced later, PerkinElmer said.

"The divestiture on (the) surface improves the growth profile of the company," Evercore analyst Vijay Kumar said in a note.

Goldman Sachs advised PerkinElmer on the deal, while Jefferies advised New Mountain Capital. (Reporting by Leroy Leo in Bengaluru and David Carnevali in New York Editing by Anirban Sen, Philippa Fletcher and Matthew Lewis)


© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
3M COMPANY -1.01% 112.99 Delayed Quote.-36.39%
EVERCORE INC. -5.56% 81.69 Delayed Quote.-39.87%
OWL ROCK CAPITAL CORPORATION -1.46% 11.49 Delayed Quote.-18.86%
PERKINELMER, INC. -0.75% 122.31 Delayed Quote.-39.17%
Latest news "Economy & Forex"
01:14pProminent Chinese commentator urges COVID experts to 'speak out'
RE
01:12pTropical Storm Ian to hit Cuba and become a hurricane
RE
12:31pItalian newly weds start married life casting votes
RE
12:21pUkraine mocks Russia's partial mobilization on Twitter
RE
12:19pIn Moldova's capital, thousands call for government's resignation
RE
12:19pSuicide bombing in Somalia kills one soldier and injures six
RE
12:17pPolice clash with people opposed to mobilisation in Russia's Dagestan
RE
12:02pCubans head to polls to vote on govt-sponsored code to legalize gay marriage, adoption
RE
11:59aFed can avoid 'deep pain' in inflation fight, Bostic says
RE
11:52aU.S. warns Putin of 'catastrophic' consequences if nuclear weapons used in Ukraine
RE
Latest news "Economy & Forex"